- Digital cancer care platform Careology and Evolent (NYSE:
EVH) to offer an innovative platform to enable cancer
navigation
- Evolent will embed Careology's digital cancer care
technology within its comprehensive care navigation services
offered to health plan clients across the U.S.
WASHINGTON, May 9, 2024
/PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a $2 billion revenue company focused on achieving
better health outcomes for people with complex conditions, today
announced it is partnering with Careology, a digital cancer care
platform, to enable more coordinated, connected and empowered
journeys for people living with cancer in the U.S.
Evolent works with more than 70 health plans — spanning
approximately 40 million unique members — to improve the quality
and affordability of care for cancer and other conditions.
The agreement will bring together Careology's "patient-first"
digital solution with Evolent's comprehensive care navigation
services. The joint offering will create a platform that connects
and empowers patients with personalized information and intuitive
tools to understand their diagnoses and treatment regimens, as well
as manage symptoms and potential treatment side-effects. These
navigation capabilities will enhance Evolent's expertise in best
practices and clinical pathways to guide cancer treatment and
tackle preventable and costly complications.
"Far too often, the experience of living with cancer is
characterized by fear, frustration and fragmentation," said Evolent
President Dan McCarthy. "With
Careology's best-in-class digital platform, we have the opportunity
to deliver a mobile, connected and coordinated experience. We
believe that when patients are more engaged and equipped to manage
their health, the better their outcomes will be."
Careology enables people with cancer to stay on top of all
aspects of their cancer treatment — such as medications and
appointments — while monitoring their symptoms and side effects and
sharing this information with providers. This data-rich digital
oversight enables premium levels of care closer to home and early
intervention if something isn't right.
Data-driven insights from the Careology platform will also help
identify patients most likely to benefit from personalized
navigation services from Evolent, enabling outreach and advocacy as
desired by the patient and their loved ones. Care navigation may
also help patients avoid the inconveniences, stress and costs
associated with preventable emergency department or hospital visits
by empowering them and their caregivers to manage symptoms.
"Bringing together our complementary capabilities we believe
will help deliver a better cancer care proposition to all
constituencies in the U.S.," said Paul
Landau, Founder and CEO of Careology. "Evolent and
Careology share a mission to support people living and dealing
with cancer, and Evolent's excellent reputation, large customer
base and comprehensive leadership in oncology specialty care make
it the optimal partner to accelerate our entry into the U.S.
market. We are excited to partner during this critical time in the
evolution of cancer care."
Evolent, which has distribution rights to Careology among U.S.
payers, plans to integrate Careology into its navigation services
across multiple lines of business and to launch the integrated
platform by the end of 2024, with a national roll-out in 2025.
This partnership comes as the World Health Organization predicts
that global cancer incidence rates will rise 77% by 2050 to make
over 35 million new cases per year. In the U.S., the sustainability
of cancer practice faces major challenges, including the rising
cost of cancer care, an oncology workforce shortage, and ongoing
chemotherapy drug shortages. Cancer care navigation could help to
relieve some of these pressures.
As part of the partnership, McCarthy will join the Careology
board.
About Evolent
Evolent (NYSE: EVH) specializes in
better health outcomes for people with complex conditions through
proven solutions that make healthcare simpler and more affordable.
Evolent serves a national base of leading payers and providers and
is consistently recognized as a top place to work in healthcare
nationally. Learn more about how Evolent is changing the way
healthcare is delivered by visiting evolent.com.
About Careology
Launched in 2019 by serial healthtech
entrepreneur, Paul Landau, after his
wife's experience with cancer, Careology is enabling a more
efficient and resilient cancer care system with leading care
providers and payors. In the UK, Careology has partnered with
leading organizations in the cancer care ecosystem including the
National Health Service (NHS), private sector healthcare providers
and private medical insurance providers. Its technology has been
recognized in the Journal of Medical Informatics which ranked
Careology as the highest scoring patient-facing cancer app
available.
For more information
Evolent press
inquiries: Jamie Manfuso, media@evolent.com
Evolent investor inquiries: Seth R. Frank,
sfrank@evolent.com
Careology inquiries: Natalie Bishop,
natalie@careology.health
View original content to download
multimedia:https://www.prnewswire.com/news-releases/evolent-and-careology-form-strategic-care-navigation-partnership-to-enhance-cancer-care-in-the-us-302141716.html
SOURCE Evolent Health, Inc.
